By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today said fourth quarter revenues for its Life Sciences & Diagnostics division rose to $681.9 million from $432.1 million a year ago.

The Washington-based conglomerate began reporting Life Sciences & Diagnostics as a separate segment this quarter. Reporting those businesses in the year-ago period also as its own segment, revenues for the three months ended Dec. 31, 2010 represented a 58 percent spike year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.